Health Care & Life Sciences » Pharmaceuticals | Wound Management Technologies Inc.

Wound Management Technologies Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
44.60
523.40
182.30
833.50
463.20
Total Accounts Receivable
221.50
278.30
452.50
794.30
836.50
Inventories
307.50
402.50
517.80
348.50
711.40
Other Current Assets
79.80
6.30
6.00
19.80
26.30
Total Current Assets
653.40
1,210.50
1,158.70
1,996.00
2,037.40
Net Property, Plant & Equipment
29.30
45.40
41.80
34.90
63.20
Intangible Assets
293.40
242.40
191.40
140.30
117.30
Other Assets
1.00
-
-
-
-
Total Assets
977.10
1,498.40
1,391.80
2,171.30
2,217.90
ST Debt & Current Portion LT Debt
1,700.60
1,597.40
619.20
418.10
1,200.00
Accounts Payable
192.20
210.30
222.40
238.20
225.50
Other Current Liabilities
1,552.90
507.40
617.50
738.00
689.90
Total Current Liabilities
3,445.70
2,315.10
1,459.10
1,394.40
2,115.30
Long-Term Debt
-
8.60
1,204.00
1,200.00
-
Total Liabilities
3,445.70
2,323.70
2,663.10
2,594.40
2,115.30
Common Equity (Total)
3,000.90
1,529.50
2,073.40
1,279.50
753.10
Total Shareholders' Equity
2,468.60
825.40
1,271.30
423.10
102.50
Total Equity
2,468.60
825.40
1,271.30
423.10
102.50
Liabilities & Shareholders' Equity
977.10
1,498.40
1,391.80
2,171.30
2,217.90
Preferred Stock (Carrying Value)
532.30
704.10
802.20
856.50
855.60

About Wound Management Technologies

View Profile
Address
1200 Summit Avenue
Fort Worth Texas 76102
United States
Employees -
Website http://www.wmgtech.com
Updated 09/14/2018
Wound Management Technologies, Inc. develops, markets and distributes biotechnology products to physicians, hospitals and clinics. It focuses on the distribution of patented collagen product, CellerateRX, Surgical Activated Collagen and HemaQuell which is FDA cleared and reimbursable under medicare part B. he company was founded by Scott A.